title: Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
authors.forename: C-H
authors.initials: CH
authors.lastname: Liu
authors.forename: C-C
authors.initials: CC
authors.lastname: Liang
authors.forename: C-J
authors.initials: CJ
authors.lastname: Liu
authors.forename: H-B
authors.initials: HB
authors.lastname: Tsai
authors.forename: P-H
authors.initials: PH
authors.lastname: Hung
authors.forename: S-J
authors.initials: SJ
authors.lastname: Hsu
authors.forename: S-I
authors.initials: SI
authors.lastname: Chen
authors.forename: J-W
authors.initials: JW
authors.lastname: Lin
authors.forename: M-Y
authors.initials: MY
authors.lastname: Lai
authors.forename: J-H
authors.initials: JH
authors.lastname: Chen
authors.forename: P-J
authors.initials: PJ
authors.lastname: Chen
authors.forename: D-S
authors.initials: DS
authors.lastname: Chen
authors.forename: J-H
authors.initials: JH
authors.lastname: Kao
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003956:Dialysis; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a